Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

New Report Shows How Supply Chain Shapes Brand-Name Medicine Prices

November 29, 2017

A new report from PhRMA is among the first to examine how money flows through the supply chain system – which includes wholesalers, pharmacy benefit managers (PBMs), pharmacies and insurers – and how that impacts what patients pay at the pharmacy.

Read More

PhRMA Statement on Report President Commissions’ Final Report with Opioid Recommendations

November 2, 2017

PhRMA is working with the (NIH) and NIDA to establish a public-private partnership that will advance the development of non-addictive pain treatment options.

Read More

Leading Biopharmaceutical Researchers to Showcase the New Era of Medicine on Capitol Hill

November 2, 2017

PhRMA is bringing more than 50 scientists and researchers from America’s biopharmaceutical companies to meet with policymakers and senior staff today on Capitol Hill.

Read More

PhRMA Statement on House Vote to Repeal IPAB

November 2, 2017

PhRMA applauds the House for taking much needed action to repeal the Independent Payment Advisory Board (IPAB). This Board of unelected bureaucrats was given virtually unchecked power to make decisions that impact more than 55 million Medicare beneficiaries – overruling Congress’ authority over the Medicare program and threatening patient access to needed medicines.

Read More

Biopharmaceutical Leaders: Japanese Patients, Health Care System and Economy Benefit from Access to Innovative Medicines

November 1, 2017

Leaders from US -based innovative biopharmaceutical companies met with Japanese government officials and other stakeholders October 30-November 1 to underscore the importance of the country’s critical role as a pro-innovation economy.

Read More

PhRMA Statement on Trump Opioids Announcement

October 26, 2017

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement.

Read More

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

October 23, 2017

On behalf of our members, PhRMA wants to thank you for your leadership in the recovery efforts in Puerto Rico after two recent hurricanes – most notably Hurricane Maria – struck the island last month.

Read More

New Analysis: 340B Program Shifting Delivery of Physician-Administered Medicines to More Expensive Hospital Settings

October 16, 2017

From 2008 to 2015, there was a significant shift in site of care from physician offices to more expensive 340B hospital outpatient settings for certain classes of physician-administered medicines, according to a new analysis by the Berkeley Research Group (BRG) that was commissioned by PhRMA.

Read More

Sharing Negotiated Discounts Could Save Patients More than $800 Annually and Would Increase Premiums About 1 Percent

October 12, 2017

Providing access to discounted medicine prices at the point of sale could save certain commercially insured patients with high deductibles and coinsurance $145 to more than $800 annually, according to a new analysis from Milliman that was commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Read More

Amgen Chairman and CEO Robert A. Bradway Elected PhRMA Board Chairman-Elect

October 11, 2017

The Pharmaceutical Research and Manufacturers of America elected new officers to its board of directors.

Read More